These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21269661)

  • 1. The effects of angiotensin-II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin-induced diabetic nephropathy.
    Tunçdemir M; Oztürk M
    Acta Histochem; 2011 Dec; 113(8):826-32. PubMed ID: 21269661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the Ku70 and apoptosis-related proteins in experimental diabetic nephropathy.
    Tunçdemir M; Öztürk M
    Metabolism; 2016 Oct; 65(10):1466-77. PubMed ID: 27621182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
    Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
    Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet transplantation restores the damage of glomerulus filtration membrane in a rat model of streptozotocin-induced diabetic nephropathy.
    Ziqiang X; Yunqiang H; Hongxing F; Jinjun W; Yong C
    J Pak Med Assoc; 2016 Mar; 66(3):296-301. PubMed ID: 26968280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
    Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy.
    Vieitez P; Gómez O; Uceda ER; Vera ME; Molina-Holgado E
    J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):96-102. PubMed ID: 18584585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis occurs differentially according to glomerular size in diabetic kidney disease.
    Jung DS; Lee SH; Kwak SJ; Li JJ; Kim DH; Nam BY; Kang HY; Chang TI; Park JT; Han SH; Yoo TH; Kang SW
    Nephrol Dial Transplant; 2012 Jan; 27(1):259-66. PubMed ID: 21652547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats].
    Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ
    Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative effects of perindopril and catechin on mesangial matrix and podocytes in the streptozotocin induced diabetic rats.
    Ertürküner SP; Başar M; Tunçdemir M; Seçkin İ
    Pharmacol Rep; 2014 Apr; 66(2):279-87. PubMed ID: 24911082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal protective effect of angiotensin II receptor antagonist on growth hormone-treated nephrotic rats].
    Li S; Cao B; Feng QH; Li XZ
    Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):817-21. PubMed ID: 14728886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats.
    Lv W; Zhang Y; Guan G; Li P; Wang J; Qi D
    Pharmacology; 2013; 92(3-4):227-34. PubMed ID: 24158161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.
    Gross ML; El-Shakmak A; Szábó A; Koch A; Kuhlmann A; Münter K; Ritz E; Amann K
    Diabetologia; 2003 Jun; 46(6):856-68. PubMed ID: 12802493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.
    Kakimoto T; Okada K; Hirohashi Y; Relator R; Kawai M; Iguchi T; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
    J Endocrinol; 2014 Jul; 222(1):43-51. PubMed ID: 24781258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extract of the aerial parts of Aster koraiensis reduced development of diabetic nephropathy via anti-apoptosis of podocytes in streptozotocin-induced diabetic rats.
    Sohn E; Kim J; Kim CS; Kim YS; Jang DS; Kim JS
    Biochem Biophys Res Commun; 2010 Jan; 391(1):733-8. PubMed ID: 19944074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
    Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transforming growth factor-β1 regulates renal α3 and β1 integrin expressions in diabetic rats: a new insight into the renoprotective effect of irbesartan].
    Zhu Y; Shen J; Hu YY; Tang JL; Liu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):1059-62. PubMed ID: 21690069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
    Zhou G; Cheung AK; Liu X; Huang Y
    Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
    Ma RX; Zhao N; Zhang W
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extract of Rhizoma Polygonum cuspidatum reduces early renal podocyte injury in streptozotocin‑induced diabetic rats and its active compound emodin inhibits methylglyoxal‑mediated glycation of proteins.
    Sohn E; Kim J; Kim CS; Jo K; Kim JS
    Mol Med Rep; 2015 Oct; 12(4):5837-45. PubMed ID: 26299942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of angiotensin II receptor antagonist on rat podocyte injury in early diabetic nephropathy].
    Long HB; Zhong J; Wei LB; Zhou WD; Xu ZZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):505-8. PubMed ID: 17545045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.